Huber et al. found that inhibition of NF-κB could block EMT and affect epithelial plasticity and metastasis of breast cancer; on the contrary, activation of NF-κB promotes EMT in breast cancer cells [26]. This evidence concerns the gene NFKB1 and breast carcinoma.